Forbes

This article discusses how to best support a person facing cancer and the social isolation that is often a consequence.

Psychedelic medicine is moving into mainstream healthcare, attracting investors, clinics and patients. But is it a real breakthrough—or the next market bubble?

Humana reported first quarter net income of nearly $1.2 billion as costs of care for older adults in its Medicare Advantage plans eased a bit but remained high.

Tower Records was born in a drugstore. At its height, it had 200 locations and generated $1 billion in revenue in the late 90s. Then, in less than a decade, it was gone.

Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating radionuclide therapies.

Health insurer Centene reported first quarter net income of $1.5 billion despite a 2 million enrollee drop in Obamacare enrollment.

Examples of behavioral changes suggest the power of messaging when disseminated from a bully pulpit. Kennedy’s conspicuous visibility reinforces his reach.

Mike Bloomberg announced an additional $350 million commitment towards road safety against what's been the leading cause of deaths worldwide for 5 to 29 year olds.

This article addresses the emerging use of adjuncts, such as 3D ultrasound, in breast cancer screening.

TrumpRx has signed deals with 86% of the branded drug market. But are prices actually falling for most Americans? A doctor takes a closer look at who benefits and what's next.